Argenx Se (ARGX) Accounts Payables (2015 - 2025)

Argenx Se (ARGX) posted Accounts Payables of $1.3 billion for Q4 2025, down 99.88% on a QoQ basis from $1016.2 billion in Q2 2025, and up 94.95% year-over-year from $650.0 million in Q4 2024.

Argenx Se (ARGX) Accounts Payables (2015 - 2025) Analysis & Trends

Argenx Se's Accounts Payables history runs 11 years deep, the most recent figure standing at $1.3 billion for Q4 2025.

  • Quarterly Accounts Payables rose 94.95% year-over-year to $1.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 billion (up 94.95% YoY) and the FY2025 annual result came in at $1.3 billion, up 94.95% from the prior year.
  • Accounts Payables was $1.3 billion for Q4 2025 at Argenx Se, down from $1016.2 billion in the prior quarter.
  • Across five years, Accounts Payables topped out at $1016.2 billion in Q2 2025 and bottomed at $208.8 million in Q4 2021.
  • A 5-year average of $102.0 billion and a median of $362.0 million in 2023 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2021 — Accounts Payables dropped 21.89% — and 2025, when it jumped 211675.45%.
  • Argenx Se's Accounts Payables stood at $208.8 million in 2021, then jumped by 41.57% to $295.7 million in 2022, then surged by 40.02% to $414.0 million in 2023, then soared by 57.0% to $650.0 million in 2024, then jumped by 94.95% to $1.3 billion in 2025.
  • Business Quant data shows ARGX's Accounts Payables at $1.3 billion in Q4 2025, $1016.2 billion in Q2 2025, and $650.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 5.74 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 10.62 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 8.64 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 423.55 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 80.54 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 126.63 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.27 Bn
Jun 30, 2025 1,016.16 Bn
Dec 31, 2024 649.99 Mn
Jun 30, 2024 479.83 Mn
Dec 31, 2023 414.01 Mn
Jun 30, 2023 309.99 Mn
Dec 31, 2022 295.68 Mn
Jun 30, 2022 257.69 Mn
Dec 31, 2021 208.85 Mn
Jun 30, 2021 239.44 Mn
Dec 31, 2020 267.39 Mn
Jun 30, 2020 140.82 Mn
Dec 31, 2019 64.67 Mn
Jun 30, 2019 61.88 Mn
Dec 31, 2018 27.57 Mn
Jun 30, 2018 25.73 Mn
Dec 31, 2017 18.00 Mn
Jun 30, 2017 14.37 Mn
Dec 31, 2016 4.73 Mn
Dec 31, 2015 2.07 Mn